3,4-dihydroxyphenylacetic acid has been researched along with ganstigmine in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Amoroso, S; Cassano, T; Castrignanò, S; Colaianna, M; Cuomo, V; Giustino, A; Steardo, L; Trabace, L | 1 |
1 other study(ies) available for 3,4-dihydroxyphenylacetic acid and ganstigmine
Article | Year |
---|---|
Neurochemical and neurobehavioral effects of ganstigmine (CHF2819), a novel acetylcholinesterase inhibitor, in rat prefrontal cortex: an in vivo study.
Topics: 3,4-Dihydroxyphenylacetic Acid; Acetylcholine; Administration, Oral; Alkaloids; Analysis of Variance; Animals; Carbamates; Cholinesterase Inhibitors; Chromatography, High Pressure Liquid; Dopamine; Exploratory Behavior; Extracellular Space; Homovanillic Acid; Male; Memory; Norepinephrine; Prefrontal Cortex; Rats; Rats, Wistar; Scopolamine; Serotonin | 2007 |